[Joint Filing Agreement [ Liang Yuan Liang Yuan Bonasmart Limited Liang Yuan Director EX-99.1 2 d193821dex991.htm EX-99.1] [13D CUSIP No. G67828106 Page 2 of 7 Pages 1 Names of reporting persons Liang Yuan 2 Check the appropriate box if a member of a group (see instructions) ¨ ¨ (a) 3 SEC use only 4 Source of funds (see instructions) OO 5 ¨ 6 Citizenship or place of organization The Hong Kong Special Administrative Region of the Peoples]
[Joint Filing Agreement [ Liang Yuan Liang Yuan Bonasmart Limited Liang Yuan Director EX-99.1 2 d193821dex991.htm EX-99.1] [13D CUSIP No. G67828106 Page 2 of 7 Pages 1 Names of reporting persons Liang Yuan 2 Check the appropriate box if a member of a group (see instructions) ¨ ¨ (a) 3 SEC use only 4 Source of funds (see instructions) OO 5 ¨ 6 Citizenship or place of organization The Hong Kong Special Administrative Region of the Peoples]
[58.com Reports First Quarter 2016 Unaudited Financial Results BEIJING, June 2, 2016 --58.com Inc. (NYSE: WUBA) (“58.com” or the “Company”), China’s largest online market place serving local merchants and consumers, today reported its unaudited financial results for the first quarter ended March 31, 2016. First Quarter 2016 Financial Highlights · Total revenues were US$231.3 million, a 165.6% increase from the] []
[58.com Reports First Quarter 2016 Unaudited Financial Results BEIJING, June 2, 2016 --58.com Inc. (NYSE: WUBA) (“58.com” or the “Company”), China’s largest online market place serving local merchants and consumers, today reported its unaudited financial results for the first quarter ended March 31, 2016. First Quarter 2016 Financial Highlights · Total revenues were US$231.3 million, a 165.6% increase from the] []
[Sinovac Reports Unaudited First Quarter 2016 Financial Results BEIJING, May 26, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter ended March 31, 2016. First Quarter 2016 Financial Highlights (compared to the first quarter of 2015) • Quarterly sales from continuing operations were $11.0 million, an increase] [FORM 6-K -------------- ---------- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. Nan Wang Chief Financial Officer 6-K 1 v441538_6k.htm FORM 6-K]
[Sinovac Reports Unaudited First Quarter 2016 Financial Results BEIJING, May 26, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter ended March 31, 2016. First Quarter 2016 Financial Highlights (compared to the first quarter of 2015) • Quarterly sales from continuing operations were $11.0 million, an increase] [FORM 6-K -------------- ---------- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. Nan Wang Chief Financial Officer 6-K 1 v441538_6k.htm FORM 6-K]
[STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT W I T N E S S E T H WHEREAS WHEREAS NOW THEREFORE Definitions 1. 1933 Act “ “ Affiliate “ Business Day “ Closing Date “ Company Plan “ Company’s Knowledge “ Confidential Information “ Control “ Governmental Entity “ Intellectual Property “ Lock-up Period “ Material Adverse Effect “ Material] []
[STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT W I T N E S S E T H WHEREAS WHEREAS NOW THEREFORE Definitions 1. 1933 Act “ “ Affiliate “ Business Day “ Closing Date “ Company Plan “ Company’s Knowledge “ Confidential Information “ Control “ Governmental Entity “ Intellectual Property “ Lock-up Period “ Material Adverse Effect “ Material] []
[Alibaba Group Announces Terms of Share Purchase from SoftBank Group Hangzhou, China, June 2, 2016 In conjunction with these transactions, SoftBank Group agreed to separate private placements of Alibaba ordinary shares in the amounts of US$500 million to Gamlight Pte Ltd, a wholly owned subsidiary of GIC Private Limited, and US$500 million to Aranda Investments Pte. Ltd., a wholly owned] [2 ALIBABA GROUP HOLDING LIMITED]
[Alibaba Group Announces Terms of Share Purchase from SoftBank Group Hangzhou, China, June 2, 2016 In conjunction with these transactions, SoftBank Group agreed to separate private placements of Alibaba ordinary shares in the amounts of US$500 million to Gamlight Pte Ltd, a wholly owned subsidiary of GIC Private Limited, and US$500 million to Aranda Investments Pte. Ltd., a wholly owned] [2 ALIBABA GROUP HOLDING LIMITED]
